Inadequate Use of Newer Treatments and Glycemic Control by Cardiovascular Risk and Sociodemographic Groups in US Adults with Diabetes in the NIH Precision Medicine Initiative All of Us Research Program

被引：0

作者：

Divya Devineni

Meleeka Akbarpour

Yufan Gong

Nathan D. Wong

机构：

[1] University of California Irvine,Heart Disease Prevention Program, Division of Cardiology, C240 Medical Sciences

[2] University of California,Department of Epidemiology

来源：

Cardiovascular Drugs and Therapy | 2024年 / 38卷

关键词：

Diabetes; SGLT2-inhibitors; GLP-1 receptor agonists; Cardiovascular risk;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：347 / 357

页数：10

共 18 条

[1] Inadequate Use of Newer Treatments and Glycemic Control by Cardiovascular Risk and Sociodemographic Groups in US Adults with Diabetes in the NIH Precision Medicine Initiative All of Us Research Program
Devineni, Divya
Akbarpour, Meleeka
Gong, Yufan
Wong, Nathan D.
CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (02) : 347 - 357
[2] Dyslipidemia Treatment and Lipid Control in US Adults with Diabetes by Sociodemographic and Cardiovascular Risk Groups in the NIH Precision Medicine Initiative All of Us Research Program
Akbarpour, Meleeka
Devineni, Divya
Gong, Yufan
Wong, Nathan D.
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
[3] Newer Treatments and Glycemic Control in US Adults With Diabetes Across Risk Groups, Sex, and Ethnicity: The NIH Precision Medicine Initiative (All Of Us Study)
Devineni, Divya
Akbarpour, Meleeka
Gong, Yufan
Wong, Nathan D.
AMERICAN HEART JOURNAL, 2021, 242 : 162 - 162
[4] Disparities in Composite Cardiovascular Risk Factor Control in US Adults With Diabetes in the NIH Precision Medicine Initiative All of Us Research Program
Golden, Frances D.
Gong, Yufan
Wong, Nathan D.
CIRCULATION, 2023, 148
[5] Dyslipidemia Treatment and Lipid Control in US Adults with Diabetes by Sociodemographic and Cardiovascular Risk Groups in the NIH Precision Medicine Initiative All of Us Research Program (vol 12, 1668, 2023)
Akbarpour, Meleeka
Devineni, Divya
Gong, Yufan
Wong, Nathan D.
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
[6] Statin and Icosapent Ethyl Use and Lipid Control in US Adults with Diabetes According to DM Risk Groups, Sex and Ethnicity in the NIH Precision Medicine Initiative All of Us Study
Akbarpour, Meleeka
Devineni, Divya
Gong, Yufan
Wong, Nathan D.
AMERICAN HEART JOURNAL, 2021, 242 : 165 - 165
[7] Composite cardiovascular risk factor control in US adults with diabetes and relation to social determinants of health: The All of Us research program
Golden, Frances
Tran, Johnathan
Wong, Nathan D.
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2025, 21
[8] Cardiovascular Risk Factor Control and Treatment Across the Spectrum of Patients with Atherosclerotic Cardiovascular Disease: The Precision Medicine Initiative - All of Us Study
Gong, Yufan
Wong, Nathan D.
CIRCULATION, 2021, 144
[9] The Precision Medicine Initiative's All of Us Research Program: an agenda for research on its ethical, legal, and social issues
Sankar, Pamela L.
Parker, Lisa S.
GENETICS IN MEDICINE, 2017, 19 (07) : 743 - 750
[10] Trends in Medication Use Among US Adults With Diabetes Mellitus: Glycemic Control at the Expense of Controlling Cardiovascular Risk Factors
Mann, Devin M.
Woodward, Mark
Ye, Fen
Krousel-Wood, Marie
Muntner, Paul
ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (18) : 1718 - 1720

← 1 2 →